-
Quantifying Red Blood Cell Membrane Bending Rigidity: New In
2026-07-17
This study provides a direct measurement of the bending rigidity of red blood cell cytoplasmic membranes, isolating the contribution of the lipid bilayer from the spectrin network. The findings offer a revised, lower estimate for membrane stiffness, with implications for understanding red blood cell mechanics and research on cardiovascular interventions.
-
Screening MMV Pandemic Response Box for MDR Pathogen Inhibit
2026-07-16
This study rigorously evaluated 247 compounds from the MMV Pandemic Response Box against multidrug-resistant (MDR) bacterial and fungal clinical isolates. The screen identified several compounds with potent inhibitory and bactericidal/fungicidal activity, offering new leads for combating MDR pathogens and informing future antimicrobial research.
-
Hexetidine (NSC-17764): Precision Antimicrobial Dosing for O
2026-07-16
Explore how Hexetidine (NSC-17764) enables precise antimicrobial dosing strategies for robust oral biofilm and dental plaque control. This article offers a protocol-focused, evidence-driven analysis that advances beyond generic overviews, delivering actionable insights for research and clinical assay design.
-
Mitoxantrone HCl: Applied Workflows for DNA Topoisomerase II
2026-07-15
Mitoxantrone HCl is redefining DNA topoisomerase II inhibitor research, offering unique protocols for apoptosis induction and advanced nuclear receptor modulation. Learn how to optimize your workflows, troubleshoot common pitfalls, and leverage cutting-edge findings for leukemia and cancer biology studies.
-
Mdivi-1 in ECM-Driven Mitochondrial Remodeling: Beyond Fissi
2026-07-15
Explore how Mdivi-1, a selective DRP1 inhibitor, enables novel experimental control of mitochondrial dynamics in the context of ECM signaling. This article reveals practical and mechanistic insights for apoptosis assays and neuroprotection research that are not covered in existing content.
-
PPP1R3G/PP1γ-Mediated RIPK1 Activation Drives Apoptosis & Ne
2026-07-14
Du et al. provide a mechanistic breakthrough in understanding how the phosphatase complex PPP1R3G/PP1γ dephosphorylates and activates RIPK1, enabling both apoptosis and necroptosis. This work clarifies a critical regulatory step in inflammatory cell death, with implications for disease modeling and therapeutic targeting.
-
Mecamylamine Hydrochloride in Precision Neuropsychiatric Res
2026-07-14
Explore the advanced role of Mecamylamine hydrochloride as a non-competitive nAChR antagonist in neuropsychiatric disorder research, focusing on its mechanistic applications and integration with gut-brain cholinergic signaling insights. This article delivers a scientific deep dive and practical guidance for translational studies.
-
Hexetidine (NSC-17764): In-Depth Analysis of Antimicrobial D
2026-07-13
Explore the nuanced antimicrobial dynamics of Hexetidine (NSC-17764) and its evidence-based protocols for oral infection management. This article offers advanced comparative insights and practical guidance for researchers and clinicians seeking optimized outcomes.
-
Solanesol: Technical Guidance for Polyisoprenoid Alcohol Wor
2026-07-13
Solanesol provides a high-purity polyisoprenoid alcohol for researchers studying membrane-related processes, including apoptosis, DNA repair, and metabolic enzyme assays. It should not be used in aqueous or ethanol-based solutions and is not suitable for diagnostic or medical applications.
-
SFRP1 Attenuates OSF via Wnt/β-Catenin Pathway Inhibition
2026-07-12
This study uncovers the mechanistic role of SFRP1 in alleviating oral submucous fibrosis (OSF) by reducing neutrophil infiltration and suppressing the Wnt/β-catenin pathway. Findings highlight SFRP1 as a potential therapeutic target for fibrotic oral disease and provide a critical foundation for future pathway-targeted interventions.
-
Molecular Mechanisms of Fruit Abscission in Actinidia arguta
2026-07-10
This study uses comparative transcriptomics and transient genetic transformation to dissect the hormonal and transcriptional networks governing fruit abscission in Actinidia arguta. The findings highlight key gene regulators and pathways that distinguish abscission-prone and abscission-resistant cultivars, offering a molecular framework for improving breeding and yield.
-
Ciprofloxacin in Antimicrobial Resistance Research Workflows
2026-07-09
Ciprofloxacin stands out as a precision tool for dissecting DNA replication inhibition and resistance gene transmission in bacterial models. This article delivers actionable protocol guidance, workflow optimizations, and troubleshooting strategies for advanced antimicrobial resistance research using high-purity Ciprofloxacin from APExBIO.
-
HyperFusion™ High-Fidelity DNA Polymerase: Enabling Next-Gen
2026-07-09
Explore the molecular precision and advanced inhibitor tolerance of HyperFusion high-fidelity DNA polymerase for PCR, with a focus on its transformative role in neurogenetic research. Discover how its unique fusion design delivers superior results for GC-rich and challenging templates.
-
Antimycin A4: Strategic Insight for Translational Metabolism
2026-07-08
Explore how Antimycin A4 uniquely empowers translational researchers to dissect metabolic dependencies, leveraging its dual inhibition of ATP-citrate lyase and mitochondrial electron transport. This article synthesizes mechanistic rationale, protocol guidance, and cross-domain perspectives to enable innovation in metabolic research and therapeutic exploration.
-
Iterative Discovery of TAS2R14 Ligands via FDA Drug Library
2026-07-08
This study presents a mixed computational and experimental strategy to identify both agonists and antagonists for the promiscuous GPCR TAS2R14, leveraging an FDA-approved drug library and structure-guided screening. The approach resulted in the discovery of 10 new antagonists and 200 agonists, highlighting the method's potential for expanding ligand space for challenging GPCR targets.
450 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page